​

Revvity (RVTY) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

RVTY Stock Forecast

Revvity (RVTY) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $111.00, with a high of $122.00 and a low of $100.00. This represents a 12.25% increase from the last price of $98.89.

$95 $102 $109 $116 $123 $130 High: $122 Avg: $111 Low: $100 Last Closed Price: $98.89

RVTY Stock Rating

Revvity stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (58.62%), 12 Hold (41.38%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 29 0 12 17 Strong Sell Sell Hold Buy Strong Buy

RVTY Price Target Upside V Benchmarks

TypeNameUpside
StockRevvity12.25%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks5.51%

Price Target Trends

1M3M12M
# Anlaysts225
Avg Price Target$111.00$111.00$124.80
Last Closing Price$98.89$98.89$98.89
Upside/Downside12.25%12.25%26.20%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 252106--18
Sep, 252106--18
Aug, 252106--18
Jul, 252107--19
Jun, 253107--20
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2025Catherine Ramsey SchulteRobert W. Baird$122.00$98.6423.68%23.37%
Oct 02, 2025Barclays$100.00$91.768.98%1.12%
Jan 21, 2025Andrew CooperRaymond James$140.00$116.6020.07%41.57%
Jan 10, 2025Eve BursteinBernstein$130.00$113.8814.16%31.46%
Nov 04, 2024Paul KnightKeyBanc$132.00$124.825.75%33.48%
Oct 15, 2024Luke SergottBarclays$140.00$122.9113.90%41.57%
Jul 30, 2024Derik de BruinBank of America Securities$127.00$125.591.12%28.43%
Jul 29, 2024Tycho PetersonJefferies$125.00$125.29-0.23%26.40%
Jul 29, 2024Daniel AriasStifel Nicolaus$110.00$120.16-8.46%11.23%
Jul 29, 2024Vijay KumarEvercore ISI$126.00$120.164.86%27.41%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 15, 2025GuggenheimNeutralinitialise
May 01, 2025UBSNeutralBuyupgrade
Feb 03, 2025KeyBancOverweightOverweighthold
Feb 03, 2025BarclaysOverweightOverweighthold
Jan 21, 2025Raymond JamesOutperformOutperformhold
Jan 10, 2025BernsteinMarket Performdowngrade
Nov 04, 2024KeyBancOverweightOverweighthold
Oct 15, 2024BarclaysEqual-WeightOverweightupgrade
Aug 27, 2024Wells FargoEqual-Weightinitialise
Jul 30, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$2 $4 $6 $8 $10 $12 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.53$8.12$4.51$5.56$2.30----
Avg Forecast$7.36$11.04$7.78$4.56$4.85$4.98$5.59$6.21$6.64
High Forecast$7.41$11.12$7.86$4.59$4.87$5.18$5.91$6.32$6.76
Low Forecast$7.27$10.90$7.63$4.54$4.79$4.87$4.91$6.12$6.54
Surprise %-11.28%-26.45%-42.03%21.93%-52.58%----

Revenue Forecast

$3B $3B $4B $4B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$3.78B$5.07B$3.31B$2.75B$2.76B----
Avg Forecast$3.65B$4.98B$4.59B$2.73B$2.75B$2.86B$3.05B$3.23B$3.30B
High Forecast$3.67B$5.00B$4.63B$2.74B$2.79B$2.89B$3.06B$3.25B$3.34B
Low Forecast$3.62B$4.93B$4.52B$2.70B$2.74B$2.83B$3.04B$3.21B$3.26B
Surprise %3.53%1.83%-27.83%0.68%0.04%----

Net Income Forecast

$0 $300M $600M $900M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$727.89M$943.16M$569.18M$693.09M$270.38M----
Avg Forecast$918.64M$1.38B$971.53M$569.72M$602.42M$627.36M$675.00M$776.55M$828.50M
High Forecast$925.45M$1.39B$981.56M$572.85M$607.42M$646.75M$737.60M$789.41M$843.15M
Low Forecast$906.94M$1.36B$952.74M$566.60M$597.43M$607.97M$612.39M$763.68M$815.67M
Surprise %-20.77%-31.54%-41.41%21.65%-55.12%----

RVTY Forecast FAQ

Is Revvity stock a buy?

Revvity stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 12 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Revvity is a favorable investment for most analysts.

What is Revvity's price target?

Revvity's price target, set by 29 Wall Street analysts, averages $111 over the next 12 months. The price target range spans from $100 at the low end to $122 at the high end, suggesting a potential 12.25% change from the previous closing price of $98.89.

How does Revvity stock forecast compare to its benchmarks?

Revvity's stock forecast shows a 12.25% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (5.51%).

What is the breakdown of analyst ratings for Revvity over the past three months?

  • October 2025: 11.11% Strong Buy, 55.56% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 11.11% Strong Buy, 55.56% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 11.11% Strong Buy, 55.56% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Revvity’s EPS forecast?

Revvity's average annual EPS forecast for its fiscal year ending in December 2025 is $4.98, marking a 116.52% increase from the reported $2.3 in 2024. Estimates for the following years are $5.59 in 2026, $6.21 in 2027, and $6.64 in 2028.

What is Revvity’s revenue forecast?

Revvity's average annual revenue forecast for its fiscal year ending in December 2025 is $2.86B, reflecting a 3.82% increase from the reported $2.76B in 2024. The forecast for 2026 is $3.05B, followed by $3.23B for 2027, and $3.3B for 2028.

What is Revvity’s net income forecast?

Revvity's net income forecast for the fiscal year ending in December 2025 stands at $627.36M, representing an 132.02% increase from the reported $270.38M in 2024. Projections indicate $675M in 2026, $776.55M in 2027, and $828.5M in 2028.